VigorMeds Tirzepatide Review: Injection, Sublingual and Renewal

VigorMeds currently lists tirzepatide injection from $399 and sublingual tirzepatide from $233, alongside a first-month $100 promotion. Those are different formulations and starting displays, not a verified identical treatment or permanent all-dose quote.¹

Its terms describe automatic subscriptions and require cancellation at least 30 days before renewal processing. They also describe a first-enrollment refund provision that should be distinguished from returns of prescription products.² This review concerns public information, without a purchase or personal clinical experience.

Two formulations need separate comparisons

The current homepage's treatment flow names tirzepatide and gives separate injection and sublingual starting amounts. It describes payment upon medical approval and clinical follow-up.¹

A lower sublingual headline is not evidence of equivalent absorption, dosing or weight-loss results. Ask which formulation the clinician proposes, what evidence supports it and what approved alternatives are appropriate. Trial results for approved injections do not independently validate a compounded sublingual product.

The product names also do not establish a complete quantity. Obtain the concentration or tablet/drop strength, prescribed schedule, number of doses and days supplied. A starting price with unknown supply cannot reliably be compared with a fixed 30-day package elsewhere.

The first-month promotion is not the renewal rate

The site advertises $100 off the first month. It does not establish that every patient, dose, plan and formulation qualifies or that the reduction continues after the introductory period.¹

Request one written quote showing the amount charged first, the renewal amount, supplies, delivery, follow-up and required tests. Do not automatically subtract $100 from every displayed figure or combine offers without confirmation. Also ask whether the selected price depends on a longer commitment.

The terms describe a bundled subscription amount that can include platform, provider and pharmacy charges where applicable. They also describe responsibility for fees and state-dependent service availability.² The final order should identify each inclusion clearly enough to compare it with another care model.

A long cancellation notice matters

The terms say subscriptions renew automatically and cancellation takes effect at the end of the current period. They require at least 30 days' notice before the applicable renewal processing date.²

That deadline can substantially limit month-to-month flexibility. Ask for the next charge date and the last date to stop it before authorizing payment. A general cancel-anytime phrase does not mean cancellation on the next billing day prevents that charge.

If a pause is offered, confirm when billing resumes. If reactivating after cancellation, the terms describe a reactivation payment together with a new subscription charge in certain circumstances.² Establish that cost before restarting rather than assuming it is only an ordinary refill.

Read the refund provision precisely

The terms describe eligibility for a refund of the first month's fee when an initial membership is canceled within 30 days, with immediate loss of access. They separately state that other product refunds, returns or exchanges are not accepted, and describe no ordinary refund after the initial period.²

These statements should not be presented as an unconditional promise to return the price of dispensed prescription medicine. Ask which component the first-month provision covers and how it interacts with medical approval and pharmacy processing. Obtain the answer for the actual product before buying.

A subscription cancellation, a medical decision to stop treatment and a pharmacy return are different processes. Keep the quote, policy and cancellation confirmation in case a billing question arises.

State access and pharmacy identity

The website displays a list of states, while the terms qualify services by current state rules and eligibility. A public list is not proof that a particular clinician or formulation is available to an individual patient.¹² Check the specific service before payment.

The inspected material does not identify the pharmacy assigned to a particular order. Obtain its legal name, contact information and state authorization, plus the formulation, storage requirements and written administration instructions. Do not use a marketing preference selector as dosing guidance.

FDA explains that compounded GLP-1 drugs are not FDA-approved and do not receive its premarket safety, effectiveness or quality review.³ Testimonials and platform descriptions do not independently establish a particular patient's outcome or the quality of a dispensed preparation.

Our assessment

VigorMeds provides named formulation choices and useful contract details. Its most important purchase limitations are the incomplete dose-and-supply quote, the promotion's eligibility and the 30-day renewal notice. Resolve those before treating either starting amount as the full cost.

Compare other provider reviews, the oral tirzepatide guide and approved Zepbound costs on the actual prescribed formulation, total payment and clinical access.

To compare how starting amounts differ from a formulation-specific treatment quote, see Iron Med Rx and Stealth.